Guangzhou Jet Bio-Filtration Co., Ltd. (SHA:688026)

Market Cap	1.79B -15.1%
Revenue (ttm)	549.40M -6.0%
Net Income	27.53M -65.8%
EPS	0.20 -64.5%
Shares Out	137.63M
PE Ratio	65.48
Forward PE	22.41
Dividend	0.07 (0.57%)
Ex-Dividend Date	Jul 2, 2025

Volume	9,685,958
Open	12.94
Previous Close	13.00
Day's Range	12.85 - 15.60
52-Week Range	12.50 - 21.66
Beta	0.50
Analysts	Strong Buy
Price Target	20.00 (+32.45%)
Earnings Date	Aug 24, 2026

About SHA:688026

Guangzhou Jet Bio-Filtration Co., Ltd. researches, develops, manufactures, and sells biological laboratory consumable products. Its products include bioprocess, biological culture, liquid handling and storage, filtration products, molecular biology, cellsafe, medical consumables, biological reagents, laboratory equipment, petri dishes, ELISA plates, immuno micro plates, inoculating loops and needles, cuvettes, latex powder-free gloves, NBR gloves, and other products. The company was founded in 2001 and is headquartered in Guangzhou, China.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2001
• Employees: 1,490
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688026

Financial Performance

In 2025, SHA:688026's revenue was 563.98 million, an increase of 0.95% compared to the previous year's 558.66 million. Earnings were 48.24 million, a decrease of -36.23%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 18, 2026

Data Sources Report a data error